Literature DB >> 28415

Withdrawal of clonidine: effects of varying dosage or duration of treatment on subsequent blood pressure and heart rate responses.

H F Oates, L M Stoker, J C Monaghan, G S Stokes.   

Abstract

The influence of the dosage or duration of treatment on the incidence and severity of clonidine withdrawal responses was examined in normotensive rats. Clonidine (0.01 or 0.1 mg/kg i.m.) was administered either in single doses, or twice daily for 3 days or 3 weeks. Rats were then anesthetized and arterial catheters were inserted. Significant overshoots in blood pressure and heart rate, reaching peak values 16 to 26 hr after the last injection, occurred in all clonidine-treated rats, but in no control rats. The overshoots after single injections of clonidine were as great as those after suspension of sustained treatment. Moreover, withdrawal responses were as great after the low dose as they were after the 10-fold greater dose. Only plasma renin activity showed a significantly greater elevation during withdrawal of the high dose of clonidine. Since ganglionic blockade reduced blood pressures and heart rates to the same levels in rats with clonidine withdrawal hypertension as in control rats, the withdrawal overshoots appear to be nervously mediated. Neither the dosage nor the duration of treatment could be shown to determine the magnitude of the response to withdrawal of clonidine.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 28415

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  An increase in cardiac alpha 1-adrenoceptors following chronic clonidine treatment.

Authors:  S Yamada; H I Yamamura; W R Roeske
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-08       Impact factor: 3.000

2.  Reinforcing properties of clonidine in rhesus monkeys.

Authors:  W L Woolverton; W D Wessinger; R L Balster
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

3.  Proceedings of the British Pharmacological Society. 16--18th December, 1980.

Authors: 
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

4.  Withdrawal of centrally acting antihypertensives in conscious dogs [proceedings].

Authors:  D P Clough; J Keddie; S J Pettinger
Journal:  Br J Pharmacol       Date:  1980-01       Impact factor: 8.739

5.  Temporal linear mode complexity as a surrogate measure of the effect of remifentanil on the central nervous system in healthy volunteers.

Authors:  Byung-Moon Choi; Da-Huin Shin; Moon-Ho Noh; Young-Hac Kim; Yong-Bo Jeong; Soo-Han Lee; Eun-Kyung Lee; Gyu-Jeong Noh
Journal:  Br J Clin Pharmacol       Date:  2011-06       Impact factor: 4.335

6.  Effect of prolonged clonidine treatment and its withdrawal on noradrenaline turnover in the cerebral cortex and medulla oblongata of the spontaneously hypertensive rat.

Authors:  J Atkinson; N Boillat; T Dennis; S Z Langer; B Scatton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

7.  Clonidine dependence in the guinea-pig isolated ileum.

Authors:  H O Collier; N J Cuthbert; D L Francis
Journal:  Br J Pharmacol       Date:  1981-06       Impact factor: 8.739

8.  Effect of chronic clonidine treatment on the turnover of noradrenaline and dopamine in various regions of the rat brain.

Authors:  L Rochette; A M Bralet; J Bralet
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

9.  Role of L-type calcium channels on yohimbine-precipitated clonidine withdrawal in vivo and in vitro.

Authors:  M Barrios; I Robles; J M Baeyens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.